
pulse tile story
the
Founder and CEO of Pulsatile Innovations, Elleesha King, has been an ambulance paramedic and registered nurse for over ten years. While often working alone in remote and rural areas, Elleesha found herself having to juggle multiple tasks during cardiac arrest emergencies, especially when trying to accurately check for a pulse. She began to wonder if this was a common problem and why there wasn't a simple tool to help rescuers in these situations.
After looking into the issue and talking with colleagues, Elleesha realized that many healthcare professionals shared the same struggle in checking a pulse quickly. Some guidelines recommend finding a pulse within 5 seconds, but Elleesha questioned how realistic that was in high-pressure situations.


Since coming up with the idea for Pulse Tile, Elleesha has heard many stories from colleagues and reflected on her own experiences where such a device could have made a critical difference in saving lives or preventing severe disabilities after cardiac arrest.
In 2023, Elleesha took a big step by raising funds through extra work shifts and self-funded the development of an initial prototype. Since then, she and the Pulsatile Innovations team have been building connections in the medical tech and startup world, seeking more funding and building strong partnerships to bring Pulse Tile to market as a life-saving product.
to date
progress
April 2024
Pulse Tile TM becomes "patent pending"
June 2024
Receipt of Stage 1 prototype
June 2024
Accepted into CSIRO's Innovate to Grow' program
June 2024
Accepted into MedTech Actuator accelerator program
June 2024
Accepted into Swinburne's Initiate program
Establishment of Advisory Board
July 2024
Overseas IP strategy established
Accepted into Swinburne's Elevate program including $20k equity free funding
September 2024
Accepted into Flinders University Medical Device. Partnering program
October 2024
Accepted into MedTech Actuator's Intensive Bootcamp
September 2023
Engaged with Boost Design for initial research and prototype development
October 2024
Accepted into AUSCEP clinical innovators program